MedTrace Logo

Trial of Treatment for Internalized Stigma in Schizophrenia

NCT02421237 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2018-08-07

No results posted yet for this study

Summary

The purpose of the present study is to build upon the investigators' previous exploratory intervention development study by conducting an adequately-powered, randomized controlled trial of the Narrative Enhancement/Cognitive Therapy (NECT) intervention among persons with schizophrenia-spectrum disorders.

Conditions

Interventions

BEHAVIORAL

Narrative Enhancement and Cognitive Therapy

BEHAVIORAL

Supportive Group Therapy

Sponsors & Collaborators

  • Rutgers University

    collaborator OTHER

  • Indiana University

    collaborator OTHER

  • John Jay College of Criminal Justice, City University of New York

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02421237 on ClinicalTrials.gov